AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 282: F245-F255, 2002. First published August 15, 2001; doi:10.1152/ajprenal.0038.2001
0363-6127/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/F245    most recent
0038.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inscho, E. W.
Right arrow Articles by Cook, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inscho, E. W.
Right arrow Articles by Cook, A. K.
Vol. 282, Issue 2, F245-F255, February 2002

P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade

Edward W. Inscho and Anthony K. Cook

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana 70112; and Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912-3000

Experiments were performed to determine the role of L-type calcium channels on the afferent arteriolar vasoconstrictor response to ATP and UTP. With the use of the blood-perfused juxtamedullary nephron technique, kidneys were perfused at 110 mmHg and the responses of arterioles to alpha ,beta -methylene ATP, ATP, and UTP were determined before and during calcium channel blockade with diltiazem. alpha ,beta -Methylene ATP (1.0 µM) decreased arteriolar diameter by 8 ± 1% under control conditions. This response was abolished during calcium channel blockade. In contrast, 10 µM UTP reduced afferent arteriolar diameter to a similar degree before (20 ± 4%) and during (14 ± 4%) diltiazem treatment. Additionally, diltiazem completely prevented the vasoconstriction normally observed with ATP concentrations below 10 µM and attenuated the response obtained with 10 µM ATP. These data demonstrate that L-type calcium channels play a significant role in the vasoconstrictor influences of alpha ,beta -methylene ATP and ATP but not UTP. The data also suggest that other calcium influx pathways may participate in the vasoconstrictor response evoked by P2 receptor activation. These observations support previous findings that UTP-mediated elevation of intracellular calcium concentration in preglomerular vascular smooth muscle cells relies primarily on calcium release from intracellular pools, whereas ATP-mediated responses involve both voltage-dependent calcium influx, through L-type calcium channels, and the release of calcium from intracellular stores. These results support the argument that P2X and P2Y receptors influence the diameter of afferent arterioles through activation of disparate signal transduction mechanisms.

afferent arterioles; calcium channels; cytosolic calcium; renal microcirculation; P2X receptors; P2Y receptors; adenosine 5'-triphosphate; uridine 5'-triphosphate; alpha ,beta -methylene adenosine 5'-triphosphate; cadmium


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
E. W. Inscho, A. K. Cook, R. C. Webb, and L.-M. Jin
Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F590 - F597.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Hultstrom, E. Y. Lai, Z. Ma, O. Kallskog, A. Patzak, and A. E. G. Persson
Adenosine triphosphate increases the reactivity of the afferent arteriole to low concentrations of norepinephrine
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2225 - R2231.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Z. Guan, D. A. Osmond, and E. W. Inscho
Purinoceptors in the Kidney
Experimental Biology and Medicine, June 1, 2007; 232(6): 715 - 726.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
X. Zhao, A. K. Cook, M. Field, B. Edwards, S. Zhang, Z. Zhang, J. S. Pollock, J. D. Imig, and E. W. Inscho
Impaired Ca2+ Signaling Attenuates P2X Receptor-Mediated Vasoconstriction of Afferent Arterioles in Angiotensin II Hypertension
Hypertension, September 1, 2005; 46(3): 562 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
B. K. Kishore, J. Isaac, M. Fausther, S. R. Tripp, H. Shi, P. S. Gill, N. Braun, H. Zimmermann, J. Sevigny, and S. C. Robson
Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1032 - F1043.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. Zhao, J. R. Falck, V. R. Gopal, E. W. Inscho, and J. D. Imig
P2X Receptor-Stimulated Calcium Responses in Preglomerular Vascular Smooth Muscle Cells Involves 20-Hydroxyeicosatetraenoic Acid
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1211 - 1217.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online